yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
Red Hat
The Opening of Virtualization
User Environment Management – The Third Layer of the Desktop
Cloud Computing for Business Agility
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Return on Assests: Bringing Visibility to your SOA Strategy
Managing Hybrid Endpoint Environments
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
How Can AJAX Improve Homeland Security?
Beyond Widgets: What a RIA Platform Should Offer
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
Today's Top SOA Links

First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed

LOS ANGELES, Dec. 6, 2012 /PRNewswire/ -- Dr. Rongxiang Xu, the founder of "human body regenerative restoration science" and a renowned life scientist and medical scientist, has filed a lawsuit today against The Nobel Assembly at Karolinska Institutet, a Swedish corporation, aka, Nobelforsamlingen. The Nobel Assembly at Karolinska Institutet is a body which awards the Nobel Prize in Physiology or Medicine. The suit filed in Superior Court of the State of California, Orange County Central Justice Center cites Libel and unfair competition.

Dr. Xu, one of the leading scientists in the world, discovered in 1984 the existence of "regenerative cell" which was confirmed to be keratin-19 positive stem cell after 2000 (US patent 6991813B2), during his study of burn treatments that has benefited 20 million burn victims in 73 countries, claims his good reputation in the community was defamed by a statement published by defendants, The Nobel Assembly, causing damages to Dr. Xu by their conduct. The suit alleges The Nobel Assembly has been successful in garnering media attention for their Nobel Prize announcements in essentially every major news organizations and publications world-wide, proving they can affect the perception of an individual by misreporting information.

"My main priority for filing this suit was to clarify the Academy's mistaken and misleading statements for the preservation of humanity and future generations, life science research should not desecrate the nature of human life," stated Dr. Xu.

On October 8, 2012, The Nobel Prize in Physiology or Medicine 2012 was awarded jointly to Sir John B. Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent," which was covered extensively in the media. 

In an abstract published on its website made in conjunction with the selection, The Nobel Assembly described the scientists' discovery.  The Nobel Assembly claims that the scientists' discovery "represents a paradigm shift in our understanding of cellular differentiation and of the plasticity of the differentiated state."  The abstract goes on to claim that: "[t]ogether, Gurdon and Yamanaka have transformed our understanding of cellular differentiation.  They have demonstrated that the usually very stable differentiated state can be unlocked because it harbours a potential for reversion to pluripotency.  This discovery has introduced fundamentally new research areas, and offers exciting new opportunities to study disease mechanisms."

Dr. Xu believes, and alleges the Statement made by The Nobel Assembly is false as he was the scientist who made the discovery a decade earlier, therefore defaming his exemplary reputation.  The Nobel Assembly states that the scientists who won the Nobel Prize "have transformed our understanding of cellular differentiation" because "[t]hey have demonstrated that the usually very stable differentiated state can be unlocked because it harbours a potential for reversion to pluripotency."  Those scientists did not demonstrate as such.  It was ten years earlier that Dr. Xu made that discovery when he was able to explain how his discovery unlocked a somatic cell's potential to revert to pluripotent stem cell in situ. 

The Nobel Assembly's use of the word "unlocked" compounds the falsity of the statement because it suggests that the scientists who won the Nobel Prize are harnessing an inherent ability of a somatic cell to revert to its pluripotent state through natural means that do not alter the cells integrity. If the Nobel Prize scientists' findings consisted of leaving a somatic cell intact and unmodified, such as Dr. Xu's finding, then the Statement would have been true and accurate.  However, the Nobel Prize scientists' discovery actually consists of the creation of an altered cell having nothing to do with human body pluripotent stem cell.  The Academy also falsely stated that "[t]his discovery has introduced fundamentally new research areas, and offers exciting new opportunities to study disease mechanisms" which is also inaccurate.

The Statements made by the defendant has tainted and damaged Dr. Xu's achievements in the eyes of the scientific community, business, potential investors and his ability to continue to be selected as a top keynote speaker for several major international conferences.

The Plaintiff is represented by the Ardent Law Group in California, case number:  30-2012-00615804. Please contact Jane Westgate 336.608.4439 or Cheryl Riley 703.683.1798.

SOURCE Mebo International

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Intuit uses deep-data analytics to gain a 360-degree view of its TurboTax application's users’ behavior and preferences for rapid applications improvements. The next BriefingsDirect big-data innovation case study highlights how Intuit uses deep-data analytics to gain a 360-degree view...
Here’s the thing: as sure as we’ll have another record-setting year for NFL streaming, you can also be sure that apps will fail and streaming services will go down. Whether you are dabbling in streaming or diving in whole-hog, you need to know what to do to give your users the most rel...
In today’s pharmaceutical supply chain, counterfeit activity is thriving. As pharma companies have expanded target markets and outsourced production over the last decade, the supply chain has become increasingly global, virtual, and vulnerable. Illicit activity has thrived, and patient...
Certain CIOs for incomprehensible reasons keep off their cloud transformation projects several key IT disciplines including Enterprise Architecture (EA), IT Service Management (ITSM) and most importantly Project Management. Do they consider them obsolete? useless? irrelevant? ITaaS St...
This is how a typical software product lifecycle works : You gather requirements, build a prototype, detail out the architecture and design, develop the product, test it, deploy the product, handle migration and maintenance and ensure product support. This is a closed loop where the Pr...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers